Close
Close
Actinium Receives Positive from EMA for AML
132 views
1.0
1.0 from 1 vote

Executive Chairman of Actinium Pharmaceuticals discusses his company's positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) related to the EU approval pathway for Actinium, an Acute Myeloid Leukemia (AML) drug.

Learn more about:

Access Programs

by Abidemi Uruejoma
5 views 7 hours ago
by Abidemi Uruejoma
1 views 8 hours ago
by Abidemi Uruejoma
31 views 1 week ago
by Abidemi Uruejoma
17 views 1 week ago
by Abidemi Uruejoma
19 views 1 week ago
by Abidemi Uruejoma
32 views 2 weeks ago
by Abidemi Uruejoma
21 views 2 weeks ago
1.0
1.0 from 1 vote
Free Newsletter
Find a Clinical Trial
Related Videos